Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Predicting Glioma Recurrence with MR-Linac Perfusion and Diffusion Imaging

EF 2025-26

Résumé
While Gliomas are the most common type of primary brain cancer, survival remains poor. These tumours almost always return, or recur, after standard treatment: surgery, chemotherapy, and six weeks of radiation therapy. In radiation therapy, high-energy beams are directed at tumours, and clinicians use scans to determine which areas of the brain should receive radiation and at what dose. These treatment plans are based only on scans taken before radiation therapy begins, even though tumours often change in shape and size. My research uses an MR-Linac, a new machine that combines magnetic resonance imaging (MRI) and radiation delivery. Because it can take scans during each radiation session, the MR-Linac allows radiation plans to be updated. Predicting where tumours are likely to recur could allow higher radiation doses to be delivered to these high-risk areas. Previous studies suggest that diffusion imaging, which measures cell density, can moderately predict where tumours will recur. However, perfusion imaging, which measures blood flow, may improve this prediction of recurrence because aggressive tumours often have more blood vessels compared to healthy areas. I will analyse previously collected MRI scans from glioma patients treated at the Odette Cancer Centre on an MR-Linac. I will compare perfusion (blood flow) in regions that recur with those that do not. Then, I will develop a model to predict recurrence using both perfusion and diffusion (cell density) imaging. I will evaluate if perfusion imaging, diffusion imaging or a combination of both is best at predicting tumour recurrence. This work will clarify how blood flow relates to recurrence, and this project will support future work on targeted radiotherapy that aims to improve survival for patients with glioma.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
572746
Name
Fung Katelin A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Predicting Glioma Recurrence with MR-Linac Perfusion and Diffusion Imaging
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Adaptive Radiotherapy; Arterial Spin Labelling; Brain Tumour; Diffusion; Diffusion Weighted Imaging; Glioma; Magnetic Resonance Imaging; Mr-Linac; Perfusion; Response Assessment
Abstract
While Gliomas are the most common type of primary brain cancer, survival remains poor. These tumours almost always return, or recur, after standard treatment: surgery, chemotherapy, and six weeks of radiation therapy. In radiation therapy, high-energy beams are directed at tumours, and clinicians use scans to determine which areas of the brain should receive radiation and at what dose. These treatment plans are based only on scans taken before radiation therapy begins, even though tumours often change in shape and size. My research uses an MR-Linac, a new machine that combines magnetic resonance imaging (MRI) and radiation delivery. Because it can take scans during each radiation session, the MR-Linac allows radiation plans to be updated. Predicting where tumours are likely to recur could allow higher radiation doses to be delivered to these high-risk areas. Previous studies suggest that diffusion imaging, which measures cell density, can moderately predict where tumours will recur. However, perfusion imaging, which measures blood flow, may improve this prediction of recurrence because aggressive tumours often have more blood vessels compared to healthy areas. I will analyse previously collected MRI scans from glioma patients treated at the Odette Cancer Centre on an MR-Linac. I will compare perfusion (blood flow) in regions that recur with those that do not. Then, I will develop a model to predict recurrence using both perfusion and diffusion (cell density) imaging. I will evaluate if perfusion imaging, diffusion imaging or a combination of both is best at predicting tumour recurrence. This work will clarify how blood flow relates to recurrence, and this project will support future work on targeted radiotherapy that aims to improve survival for patients with glioma.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fung, Katelin A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~